Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022.

导出 LinkOut

翻译打印收藏纠错

作者： Sara S,Kim ; Jessie R,Chung ; H Keipp,Talbot ; Carlos G,Grijalva ; Karen J,Wernli ; Erika,Kiniry ; Emily T,Martin ; Arnold S,Monto ; Edward A,Belongia ; Huong Q,McLean ; Manjusha,Gaglani ; Mufaddal,Mamawala ; Mary Patricia,Nowalk ; Krissy,Moehling Geffel ; Sara Y,Tartof ; Ana,Florea ; Justin S,Lee ; Mark W,Tenforde ; Manish M,Patel ; Brendan,Flannery ; Strain Surveillance and Emerging Variants Team ; Meghan L,Bentz ; Alex,Burgin ; Mark,Burroughs ; Morgan L,Davis ; Dakota,Howard ; Kristine,Lacek ; Joseph C,Madden ; Sarah,Nobles ; Jasmine,Padilla ; Mili,Sheth

关键词 COVID‐19 outpatient vaccine effectiveness

主题词成年人(Adult);人类(Humans);门诊病人(Outpatients);RNA, 信使(RNA, Messenger)

DOI 10.1111/irv.13029

PMID 36825251

发布时间 2024-09-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交